自动乳房超音波系统市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

2024年，全球自动乳房超音波系统市场规模达22亿美元，预估年复合成长率达16.7%，2034年将达101亿美元。全球乳癌发生率的上升、对早期发现的日益重视、公共卫生意识的增强以及政府支持的筛检计划是推动该市场发展的核心因素。随着医学影像和诊断技术的快速发展，自动乳房超音波系统正逐渐成为乳癌筛检的重要工具，尤其对于乳房组织緻密的女性而言。

自动乳房超音波系统 (ABUS) 提供先进的全乳房 3D 视觉化技术，无需过度依赖操作人员的技能即可提供一致且标准化的影像。由于其能够提高检测准确性，ABUS 在医院、影像中心和专业乳房护理机构中的应用正在迅速增加。透过撷取跨组织层的高解析度影像，这些系统可支援早期诊断并改善患者预后。随着医疗机构持续重视早期癌症的识别，ABUS 与其他影像方法的整合变得更加重要。对密集乳房筛检和 AI 增强诊断的关注预计将推动全球范围内的需求和应用。

2024年，ABUS类别的市场价值最高，达到14亿美元，预计到2034年将达到65亿美元，复合年增长率为16.9%。其市场领先地位源于对人工智慧诊断日益增长的需求、人们对乳癌风险的认识不断加深，以及这些系统在医疗保健环境中用于全面筛检和详细分析的日益普及。 ABUS提供完整的3D乳房影像，使放射科医生能够识别传统乳房X光检查可能被忽视的异常。其高清晰度减少了人为错误，标准化使其成为乳房结构緻密患者乳癌检测的关键工具。

2024年，医院领域占了45.1%的份额。这些机构配备了先进的诊断技术，并拥有熟练的专业人员，使其成为ABUS的领先应用者。作为癌症筛检、诊断和治疗的中心枢纽，医院处理大量患者，并受益于公共卫生筛检项目，这进一步推动了自动化超音波系统的使用。将ABUS整合到更广泛的诊断工作流程中，使医疗保健提供者能够提供更全面、更有效率的乳房护理服务。

2024年，美国自动乳房超音波系统市场规模达7.583亿美元。这一增长与美国乳癌发病率的上升密切相关，这导致对精准早期诊断工具的需求激增。此外，美国医疗保健生态系统也受益于良好的监管环境、广泛的癌症筛检公众教育以及对医疗技术创新的大力投入。这些因素为ABUS的普及和持续的市场扩张奠定了坚实的基础。

活跃于全球自动乳腺超音波系统市场的关键公司包括西门子医疗、SonoCine, Inc.、Canon、通用电气医疗、Real Imaging、Seno Medical Instruments Inc.、Hologic、Supersonic Imagine、汕头超音波仪器研究所、Theraclion、Metritrack、QView Medical、Delphinus Medical Technologies、汕头超音波仪器研究所、Theraclion、Metritrack、QView Medical、Delphinus Medical Technologies、Rayape 和在自动乳房超音波系统市场运营的公司正在透过创新、全球扩张和合作伙伴关係的结合来加强其影响力。领先的公司正在大力投资研发，以提高影像品质、缩短扫描时间并整合基于人工智慧的解释工具。为了满足已开发市场和新兴市场日益增长的需求，製造商正在扩大其分销网络并与医院和诊断连锁店建立策略联盟。许多公司正在努力获得更快的监管部门批准，以加快产品推出，尤其是在高负担地区。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

• 产业生态系统分析
• 产业衝击力
  • 成长动力
    • 全球乳癌发生率不断上升
    • 自动乳腺超音波系统的技术进步日新月异
    • 乳房 X 光摄影对緻密型乳房组织患者的疗效有限
    • 乳癌意识的提高和政府的积极倡议
    • 全球范围内增加国家乳癌筛检项目
    • 美国乳房超音波和数位乳房断层合成检查的报销增加
  • 产业陷阱与挑战
    • 自动乳房超音波系统成本高
    • 发展中国家对ABUS的认识有限
    • 新兴国家缺乏熟练或训练有素的人才
  • 市场机会
    • 人工智慧整合的 ABUS 在乳癌预测筛检的应用日益增多
• 成长潜力分析
• 监管格局
• 技术进步
  • 当前的技术趋势
  • 新兴技术
• 供应链分析
• 2024年定价分析
• 未来市场趋势
• 差距分析
• 波特的分析
• PESTEL分析

第四章：竞争格局

• 介绍
• 公司市占率分析
  • 北美洲
  • 欧洲
  • 亚太地区
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 关键进展
  • 併购
  • 伙伴关係和合作
  • 新产品发布
  • 扩张计划

第五章：市场估计与预测：按产品，2021 - 2034 年

• 主要趋势
• 自动乳房超音波系统（ABUS）
• 自动乳腺体积扫描仪（ABVS）
• 其他产品

第六章：市场估计与预测：依最终用途，2021 - 2034 年

• 主要趋势
• 医院
• 诊断影像中心
• 专科诊所

第七章：市场估计与预测：按地区，2021 - 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 沙乌地阿拉伯
  • 南非
  • 阿联酋

第八章：公司简介

• Canon
• CapeRay Medical
• Delphinus Medical Technologies
• GE Healthcare
• Hitachi
• Hologic
• Koninklijke Philips
• Metritrack
• QView Medical
• Real Imaging
• SonoCine, Inc.
• Supersonic Imagine
• Siemens Healthineers
• Seno Medical Instruments Inc.
• Shantou Institute of Ultrasonic Instruments
• Theraclion

The Global Automated Breast Ultrasound Systems Market was valued at USD 2.2 billion in 2024 and is estimated to grow at a CAGR of 16.7% to reach USD 10.1 billion by 2034. Rising breast cancer rates across the globe, growing emphasis on early detection, strong public health awareness, and government-backed screening initiatives are among the core factors driving this market forward. With rapid advances in medical imaging and diagnostic technology, automated breast ultrasound systems are gaining ground as essential tools in breast cancer screening, especially among women with dense breast tissue.

Automated breast ultrasound systems, or ABUS, offer advanced 3D visualization of the entire breast, providing consistent and standardized imaging without relying heavily on the skill of the operator. Their implementation is rapidly increasing in hospitals, imaging centers, and specialized breast care facilities due to their ability to enhance detection accuracy. By capturing high-resolution images across tissue layers, these systems support early diagnosis and improve patient outcomes. As health organizations continue prioritizing early-stage cancer identification, the integration of ABUS alongside other imaging methods becomes even more important. The focus on dense breast screening and AI-enhanced diagnostics is expected to drive demand and adoption worldwide.

In 2024, the ABUS category held the largest market value at USD 1.4 billion and will reach USD 6.5 billion by 2034, growing at a CAGR of 16.9%. Its leadership in the market stems from increasing demand for AI-powered diagnostics, wider awareness of breast cancer risks, and the growing use of these systems across healthcare environments for thorough screening and detailed analysis. ABUS delivers full 3D breast imaging, enabling radiologists to identify abnormalities that may go unnoticed with conventional mammography. Its high clarity reduced human error, and standardization has made it a key asset in breast cancer detection for patients with dense breast composition.

The hospitals segment held a 45.1% share in 2024. These facilities are equipped with advanced diagnostic technology and have access to skilled professionals, making them leading adopters of ABUS. As central hubs for cancer screening, diagnosis, and treatment, hospitals handle high patient volumes and benefit from public health screening programs, further promoting the use of automated ultrasound systems. The integration of ABUS into broader diagnostic workflows allows healthcare providers to offer more complete and efficient breast care services.

United States Automated Breast Ultrasound Systems Market reached USD 758.3 million in 2024. This growth is closely tied to the increasing incidence of breast cancer across the country, which has led to a surge in demand for precise, early-stage diagnostic tools. The U.S. healthcare ecosystem also benefits from a favorable regulatory environment, widespread public education on cancer screening, and strong investments in medical technology innovation. These factors create a solid foundation for ABUS adoption and continued market expansion.

Key companies active in the Global Automated Breast Ultrasound Systems Market include Siemens Healthineers, SonoCine, Inc., Canon, GE Healthcare, Real Imaging, Seno Medical Instruments Inc., Hologic, Supersonic Imagine, Shantou Institute of Ultrasonic Instruments, Theraclion, Metritrack, QView Medical, Delphinus Medical Technologies, Koninklijke Philips, CapeRay Medical, and Hitachi. Companies operating in the automated breast ultrasound systems market are strengthening their presence through a combination of innovation, global expansion, and collaborative partnerships. Leading players are heavily investing in R&D to enhance image quality, reduce scan time, and integrate AI-based interpretation tools. To meet increasing demand in both developed and emerging markets, manufacturers are expanding their distribution networks and entering strategic alliances with hospitals and diagnostic chains. Many firms are working on gaining faster regulatory approvals to accelerate product rollouts, especially in high-burden regions.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/Country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis
• 2.2 Key market trends
  • 2.2.1 Regional trends
  • 2.2.2 Product trends
  • 2.2.3 End use trends
• 2.3 CXO perspectives: Strategic imperatives
  • 2.3.1 Key decision points for industry executives
  • 2.3.2 Critical success factors for market players
• 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing prevalence of breast cancer worldwide
    • 3.2.1.2 Rising technological advancements in automated breast ultrasound systems
    • 3.2.1.3 Limited capability of mammography in dense breast tissue patients
    • 3.2.1.4 Rising awareness and favorable government initiatives regarding breast cancer
    • 3.2.1.5 Increasing national breast screening programs across the globe
    • 3.2.1.6 Increased reimbursement for breast ultrasound and digital breast tomosynthesis in the U.S.
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of the automated breast ultrasound system
    • 3.2.2.2 Limited awareness of ABUS in developing countries
    • 3.2.2.3 Lack of skilled or trained personnel in emerging nations
  • 3.2.3 Market opportunities
    • 3.2.3.1 Rising adoption of AI-integrated ABUS for predictive breast cancer screening
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
  • 3.4.4 Latin America
  • 3.4.5 Middle East and Africa
• 3.5 Technological advancements
  • 3.5.1 Current technological trends
  • 3.5.2 Emerging technologies
• 3.6 Supply chain analysis
• 3.7 Pricing analysis, 2024
• 3.8 Future market trends
• 3.9 Gap analysis
• 3.10 Porter's analysis
• 3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
  • 4.2.1 North America
  • 4.2.2 Europe
  • 4.2.3 Asia Pacific
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers and acquisitions
  • 4.6.2 Partnerships and collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Automated breast ultrasound system (ABUS)
• 5.3 Automated breast volume scanner (ABVS)
• 5.4 Other products

Chapter 6 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Hospitals
• 6.3 Diagnostic imaging centers
• 6.4 Specialty clinics

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 France
  • 7.3.4 Spain
  • 7.3.5 Italy
  • 7.3.6 Netherlands
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 India
  • 7.4.3 Japan
  • 7.4.4 Australia
  • 7.4.5 South Korea
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Mexico
  • 7.5.3 Argentina
• 7.6 Middle East and Africa
  • 7.6.1 Saudi Arabia
  • 7.6.2 South Africa
  • 7.6.3 UAE

Chapter 8 Company Profiles

• 8.1 Canon
• 8.2 CapeRay Medical
• 8.3 Delphinus Medical Technologies
• 8.4 GE Healthcare
• 8.5 Hitachi
• 8.6 Hologic
• 8.7 Koninklijke Philips
• 8.8 Metritrack
• 8.9 QView Medical
• 8.10 Real Imaging
• 8.11 SonoCine, Inc.
• 8.12 Supersonic Imagine
• 8.13 Siemens Healthineers
• 8.14 Seno Medical Instruments Inc.
• 8.15 Shantou Institute of Ultrasonic Instruments
• 8.16 Theraclion